NR2F2 and neoplasm: This analysis showed significant upregulation of MIR100HG (Figure 7A), LINC01268 (Figure 7B), FTX (Figure 7C), ROR1-AS1 (Figure 7D), DNM3OS (Figure 7E), KCNQ1OT1 (Figure 7F), MAGI1-IT1 (Figure 7G), NR2F2-AS1 (Figure 7H), ADAMTS9-AS2 (Figure 7I), and PCA3 (Figure 7J) in 32 MCL tumor samples compared with the reactive tonsil B-cell subsets.